• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug launch

Richard Francis Teva CEO Teva CEO
Pharma

Teva's 1st R&D day lets CEO bask in innovative drug refresh

TD Cowen analysts left Teva's first R&D day this week feeling “increasingly confident” in the firm’s direction.
Fraiser Kansteiner , Donavyn Coffey Nov 13, 2026 11:16am
Takeda

Orzeyful gets off to races in US with 'lighter' DEA schedule

Nov 12, 2026 11:16am
Summit

Summit sheds commercial leaders before ivonescimab FDA decision

Nov 10, 2026 2:12pm
Bayer cross

Bayer nabs 1st-in-class FDA nod for stroke med asundexian

Nov 9, 2026 9:10pm
Splash celebration glitter

$200M in 5 weeks: Behind RevMed's 'eye-popping' Rasonque debut

Nov 5, 2026 11:11am
Novo Nordisk

Novo reports strong Q3 for Wegovy pill as potential launches loom

Nov 4, 2026 11:26am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings